SM
ARIA

Sabby Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Sabby Management’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,690
Closed -$987K – 418
2015
Q3 		$987K Buy
1,690
+91
+6% +$701 0.04% 237
2015
Q2 		$1.32M Hold
1,599
– – 0.05% 205
2015
Q1 		$1.32M Sell
1,599
-712
-31% -$5.26K 0.05% 171
2014
Q4 		$1.59K Sell
2,311
-126
-5% -$788 0.05% 142
2014
Q3 		$1.32K Buy
2,437
+541
+29% +$3.16K 0.05% 141
2014
Q2 		$1.21M Sell
1,896
-4,085
-68% -$28.1K 0.05% 133
2014
Q1 		$4.82M Buy
5,981
+3,672
+159% +$28.6K 0.27% 65
2013
Q4 		$1.57M Buy
2,309
+680
+42% +$3.67K 0.1% 95
2013
Q3 		$3M Buy
1,629
+1,151
+241% +$22.3K 0.19% 67
2013
Q2 		$836K Buy
+478
New +$8.47K 0.06% 126

Other funds holding ARIA

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Sabby Management's ARIA Position: Q4 2015 in Review

Sabby Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q4 2015, closing a stake of 169,000 shares — an estimated $987K sold.

Sabby Management first reported a position in ARIA in Q3 2013 and held it in 7 quarters. The position peaked at $1.43M in Q1 2015. 172 funds tracked by Wall St. Rank hold ARIA as of Q4 2015.

  • Sabby Management reported no remaining Ariad Pharmaceuticals Inc position as of Q4 2015 after selling out during the quarter.
  • Sabby Management sold 169,000 Ariad Pharmaceuticals Inc shares in Q4 2015, an estimated $987K.
  • Sabby Management first reported a position in Ariad Pharmaceuticals Inc in Q3 2013 and held it in 7 quarters.
  • Sabby Management's Ariad Pharmaceuticals Inc position peaked at $1.43M in Q1 2015.
  • 172 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q4 2015.

Based on Sabby Management's 13F filing for Q4 2015, filed 16 Feb 2016.